NRX Pharmaceuticals
NRXP
NRXP
32 hedge funds and large institutions have $4.78M invested in NRX Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 30 → 32 (+2)
0.97% more ownership
Funds ownership: 0.44% → 1.41% (+0.97%)
Holders
32
Holding in Top 10
–
Calls
$74K
Puts
$6K
Top Buyers
| 1 | +$3.39M | |
| 2 | +$421K | |
| 3 | +$291K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$103K |
| 5 |
Jane Street
New York
|
+$9.05K |
Top Sellers
| 1 | -$50.8K | |
| 2 | -$48.5K | |
| 3 | -$42.1K | |
| 4 |
VF
Virtu Financial
New York
|
-$30K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.53K |